Structure-Activity Correlationship and Strain Specificity of Polyoxometalates in Anti-human Immunodeficiency Virus Activity

Biological and Pharmaceutical Bulletin Volume 18 Issue 7 Page 996-1000 published_at 1995-07-15
アクセス数 : 556
ダウンロード数 : 147

今月のアクセス数 : 8
今月のダウンロード数 : 4
File
BiolPhamBull_18_996.pdf 833 KB 種類 : fulltext
Title ( eng )
Structure-Activity Correlationship and Strain Specificity of Polyoxometalates in Anti-human Immunodeficiency Virus Activity
Creator
Inoue Yoshio
Fujimoto Yasuhiro
Yoshida Tetsuya
Yamase Toshihiro
Source Title
Biological and Pharmaceutical Bulletin
Volume 18
Issue 7
Start Page 996
End Page 1000
Abstract
The anti-human immunodeficiency virus (HIV) activity of polyoxometalates of representative structural families, such as Keggin, lacunary Keggin, trivacant Keggin, Keggin sandwich, Wells-Dawson and Wells-Dawson sandwich, was determined using two strains of HIV type 1 (HIV-1HTLV-IIIBand HIV-1SF-2H). The compounds were preferably selected to cover both polyoxotungstates and polyoxomolybdates in each structural family. In general, polyoxotungstates of Keggin, lacumary Keggin, trivacant Keggin, Keggin sandwich, Wells-Dawson and Wells-Dawson sandwich structures showed anti-HIV-1HTLV-IIIBactivity, whereas most compounds not included in these structural categories were inactive. Among the compounds with a potent anti-HIV-1HTLV-IIIBactivity, those of Keggin and its closely related structural families (lacunary Keggin, trivacant Keggin and Keggin sandwich) inhibited the cytopathogenicity and syncytium formation caused by HIV-1SF-2Hto a much higher extent compared with HIV-1HTLV-IIIB-related ones. The difference between the spectra of anti-HIV-1HTLV-IIIBactivity and the specificity for HIV-1SF-2Hmight result from differential structural requirements in these functions.
Keywords
polyoxometalate
human immunodeficiency virus
strain specificity
syncytium formation
cytopathogenicity
NDC
Medical sciences [ 490 ]
Language
eng
Resource Type journal article
Publisher
The Pharmaceutical Society of Japan
Date of Issued 1995-07-15
Rights
© 1995 Pharmaceutical Society of Japan
Publish Type Version of Record
Access Rights open access
Source Identifier
[ISSN] 0918-6158
[ISSN] 1347-5215
[NCID] AA10885497
[DOI] 10.1248/bpb.18.996
[DOI] https://doi.org/10.1248/bpb.18.996